Vodafone Idea
Clarified that no proposal requiring disclosure is currently being considered by the board, following media reports suggesting a potential $6 billion investment from PE firm TGH.
Cipla
To acquire a 100% stake in Inzpera Healthsciences for nearly ₹111 crore, expanding its presence in the consumer healthcare segment.
Akums Drugs
Granted a patent for its invention titled ‘Dual Release Gastro-Resistant Composition’ valid for 20 years from November 19, 2022.
Rain Industries
Subsidiaries Northern Graphite and Rain Carbon receive up to €530,000 (₹4.8 crore) in R&D grant funding support.
Fabtech Technologies
Wins an order worth ₹52 crore to build a next-generation veterinary formulations facility in North Africa.
Reliance Infrastructure
Certain assets provisionally attached by the Enforcement Directorate under PMLA. The company clarified no impact on operations, shareholders, or stakeholders; Anil D. Ambani has not been on its board for over 3.5 years.
Nuvoco Vistas
Approves share purchase agreement to acquire securities of Algebra Endeavour from JSW Cement and Alpha Alternatives Holdings.
Wipro
Signs an agreement to transfer its entire stake in Drivestream India for ₹18.03 crore as part of its ongoing restructuring strategy.
Nesco
Receives approval from NHLML to develop wayside amenities at three sites on the Bengaluru–Chennai Expressway Corridor. Total development cost: ₹75 crore per site; expected annual revenue: ₹115 crore from year four.
PCBL
Receives ₹336 crore from three warrant holders and issues 1.6 crore shares upon conversion. Paid-up share capital increases to ₹393.46 crore.
RITES
Secures a construction order worth ₹372.68 crore from National Institute of Mental Health & Neurosciences (NIMHANS).
Bharti Airtel
Appoints Dinesh Kumar Khara as Additional Director for five years. Board also approves acquiring an additional 5% stake in Indus Towers and amendments to include emerging technologies in its charter.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.